-22.5% Avg body weight loss at highest dose (SURMOUNT-1) 96% Lost at least 5% body weight 72 weeks Trial duration Context: Clinical trial participants also received lifestyle intervention (diet and exercise counseling)
44, 77 Methymalonic acid, a metabolite of PPA, results in abnormal mitochondrial morphology, 78 tissue specific ETC dysfunction, 79 inhibition of the complex I and II function when interacting with complex III in the brain 80 and reductions in reduced glutathione, 78 similar to the patient cohort presented and the PPA animal model
This unique formulation supports anti-ageing effects while promoting overall skin health
Jackson, K
Vogue featured copper peptides as an intriguing anti-aging ingredient, and dermatology-focused beauty coverage has linked GHK-Cu to skin firmness, elasticity, texture, barrier support, and slow visible aging care
10.1016/j.phymed.2022.154601 73 JohnsonJ